跳至主要内容
临床试验/CTRI/2022/08/045093
CTRI/2022/08/045093尚未招募2 期

A Randomized Clinical Trial to Study the Effect of Lifestyle Modification with special reference to Aharvidhividhan and Bhojanottar vidhividhan on Agnimandya

Vidarbha Ayurved Mahavidyalaya Amravati1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年8月31日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
120
试验地点
1
主要终点
Complete Remission from Agnimandya 76-100%

研究概览

简要总结

A Randomized clinical trial will be conducted to study the effect of Lifestyle modification with special reference to Aharvidhividhan and Bhojanottar vidhividhan on Agnimandya. Trial will be conducted in our Institute . total 120 patients with Inclusive Criteria having Signs and symptoms of Agnimandya  will be selected and will be divided in two groups. one group will be advised Lifestyle modifications i.e Aharvidhividhan and Bhojanottar vidhividhan  and other group will be observed only. and result will be compared. Primary outcome will be about Evaluation of Lifestyle distrubance  and the Secondary Outcome will be about assessment criteria of effect of therapy. and results will be noted

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • subject having signs and symptoms of agnimandya like avipak, prasek, kshudhamandya, Shirogaurav, Amashay pradeshi gaurav, Shirogaurav, Antrakujan, Pravahan, malbaddhata, Jaran shakti, Abhyavharan Shakti, Mala samata patient having any 2 or more symptoms among these.
  • having symptoms not more than 2 months.

排除标准

  • patient age less than 20 and more than 60 years, patients diagnosed with any pathology of GIT such as Cancer of GIT, Liver, pancreas, gall bladder, peptic and gastric ulcer, gastro-esophageal reflux, gall stone, renal failure, hepatitis, tuberculosis will be excluded.
  • pregnant and lactating mother, people not ready to give written consent, and not ready to change their lifestyle due to occupation or duties.
  • Agnimandya caused due to medicine intake.

结局指标

主要结局

Complete Remission from Agnimandya 76-100%

时间窗: 0th day | 3rd Day | 7th Day | 14th Day | 21st Day | 28th Day | 35th Day | 42nd Day | 49th Day | 56th Day | 63th Day | 70th Day

mild improvement in Agnimandya 25-50%

时间窗: 0th day | 3rd Day | 7th Day | 14th Day | 21st Day | 28th Day | 35th Day | 42nd Day | 49th Day | 56th Day | 63th Day | 70th Day

Marked Improvement in Agnimandya 51-75%

时间窗: 0th day | 3rd Day | 7th Day | 14th Day | 21st Day | 28th Day | 35th Day | 42nd Day | 49th Day | 56th Day | 63th Day | 70th Day

次要结局

  • Remission in symptoms of anaemia(Remission in symptoms of obesity)

研究者

发起方
Vidarbha Ayurved Mahavidyalaya Amravati
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验